Mustang Bio MBIO
NASDAQ MBIO
$0.37 +0.00 (+1.27%)
As of: Oct 23, 2026 · 2:57 PM EDT

Mustang Bio (MBIO) Amortization of Deferred Charges (2016 - 2023)

Updated

Analysis

Mustang Bio (MBIO) Amortization of Deferred Charges (2016 - 2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,130.46 Bn 1,099.05 Bn 19.71 Bn
2 Johnson & Johnson 635.24 Bn 555.11 Bn 17.30 Bn
3 AbbVie 504.85 Bn 477.96 Bn 12.70 Bn
4 Merck 358.66 Bn 313.04 Bn 12.21 Bn
5 Novartis Ag 290.32 Bn 254.31 Bn 11.24 Bn
6 Astrazeneca 265.28 Bn 238.97 Bn 12.86 Bn
7 Amgen 237.85 Bn 193.25 Bn 7.24 Bn
8 Gilead Sciences 194.96 Bn 169.16 Bn 6.22 Bn
9 Pfizer 171.51 Bn 118.16 Bn 10.94 Bn
10 Mustang Bio 2.52 Mn -65.25 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2023 -25,000.00
Mar 31, 2023 143,000.00
Dec 31, 2022 142,000.00
Sep 30, 2022 143,000.00
Jun 30, 2022 148,000.00
Mar 31, 2022 19,000.00
Sep 30, 2020 1.79 Mn
Jun 30, 2020 270,000.00
Mar 31, 2020 259,000.00
Dec 31, 2019 244,000.00
Sep 30, 2019 234,000.00
Jun 30, 2019 202,000.00
Mar 31, 2019 30,000.00
Dec 31, 2016 673,000.00
API Access

Mustang Bio Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=MBIO&period=max&api_key=YOUR_API_KEY